Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions.
200$ discount available for One Nucleus members. Please contact [email protected] for the discount code.
*Guest blog by Eramol. If you would like to submit a guest blog please email [email protected].
Written by David Cox, Site Director at Eramol
*Guest blog by Eramol. If you would like to submit a guest blog please email [email protected].
Early-phase clinical programmes often face a different set of challenges compared with late-stage or commercial manufacturing.
Take the next step in your scientific career with a growing specialist CRO.
Continued demand from new and existing clients is driving further growth in our business, so we’re looking for even more talented scientists to join our team.
We currently have a number of opportunities for Scientists – Ion Channel Screening and Research Associates who want to develop their careers in a specialist CRO environment.
Why consider a career with Metrion?
Utilising enzyme-free DNA nanotechnology, immunoMUSE® kits from Amsbio enable researchers to perform ultra-sensitive, 2-plex to 4-plex custom biomarker detection in tissue while generating same-day imaging results without species or isotype constraints.
As senior scientist within LifeArc’s Molecular and Cellular Pharmacology (MCP) department, you will be part of a diverse group of scientists with a wealth of experience in the preclinical phase of drug discovery. MCP focuses on developing and applying bespoke biological cell-based assays for characterisation and screening of therapeutic assets, providing a deep understanding of their complex mechanism of action to support LifeArc’s ambitious goals to benefit patients and to make life science life changing.
We are looking for an exceptional scientist with a research focus on ensuring food safety and security.
About Vernalis
Working within our fully equipped research laboratories in Cambridge, our established group of scientists are world leaders in multiple hit-ID technologies and structure-based drug discovery.
Our scientists develop and apply lead generation and structure-based methods to solve problems in drug discovery and have generated cell active compounds and development candidates against targets in multiple therapeutic areas including oncology, neurodegeneration, anti-infectives and inflammation.
The Role